Is Spotify a Millionaire-Maker Stock?
Spotify (NYSE:SPOT) may seem like an expensive proposition trading closer…
Sell
30
KMTS Quote, Financials, Valuation and Earnings
Last price:
$22.89
Seasonality move
:
--
Day range:
$22.32 - $23.34
52-week range:
$20.00 - $26.15
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
22.66x
P/B ratio:
--
Volume:
61.5K
Avg. volume:
175.1K
1-year change:
--
Market cap:
$1.1B
Revenue:
$27.5M
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingKestra Medical Technologies has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $27.50, Kestra Medical Technologies has an estimated upside of 21.28% from its current price of $22.68.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $23.00 representing 100% downside risk from its current price of $22.68.
Fair Value
-
According to the consensus of 5 analysts, Kestra Medical Technologies has 21.28% upside to fair value with a price target of $27.50 per share.
KMTS vs. S&P 500
-
Over the past 5 trading days, Kestra Medical Technologies has underperformed the S&P 500 by -4.14% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Kestra Medical Technologies does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Kestra Medical Technologies has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Kestra Medical Technologies reported revenues of --.
Earnings Growth
-
Kestra Medical Technologies has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Kestra Medical Technologies reported earnings per share of --.
Enterprise value:
1.1B
EV / Invested capital:
--
Price / LTM sales:
22.66x
EV / EBIT:
--
EV / Revenue:
22.30x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-12.23x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2019-07-31 | 2020-07-31 | 2021-07-31 | 2020-07-31 | 2021-07-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -$12.3M | |
| EBITDA | -- | -- | -- | -- | -$12.2M | |
| Diluted EPS | -- | -- | -- | -- | -$0.28 | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | $87.9M | |
| Total Assets | -- | -- | -- | -- | $121.5M | |
| Current Liabilities | -- | -- | -- | -- | $31.3M | |
| Total Liabilities | -- | -- | -- | -- | $358M | |
| Total Equity | -- | -- | -- | -- | -$236.5M | |
| Total Debt | -- | -- | -- | -- | $43.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2019-07-31 | 2020-07-31 | 2021-07-31 | 2020-07-31 | 2021-07-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -$11.5M | |
| Cash From Investing | -- | -- | -- | -- | -$1.8M | |
| Cash From Financing | -- | -- | -- | -- | $101K | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
KMTS
Sector
Market Cap
$1.1B
--
Price % of 52-Week High
86.71%
--
Dividend Yield
0%
--
Shareholder Yield
--
--
1-Year Price Total Return
--
--
Beta (5-Year)
--
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$22.83
200-day SMA
Buy
Level
$0.00
Bollinger Bands (100)
Buy
Level
0 - 0
Chaikin Money Flow
Sell
Level
-947.2K
20-day SMA
Sell
Level
$23.74
Relative Strength Index (RSI14)
Sell
Level
46.10
ADX Line
Buy
Level
35.31
Williams %R
Neutral
Level
-74.9706
50-day SMA
Buy
Level
$0.00
MACD (12, 26)
Buy
Level
0.43
25-day Aroon Oscillator
Buy
Level
24
On Balance Volume
Neutral
Level
4.6M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Sell
CA Score
(Annual)
Level (-24.2613)
--
Beneish M-Score
(Annual)
Level (--)
--
Momentum Score
Level (--)
Sell
Ohlson Score
Level (35.74)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
Stock Forecast FAQ
In the current month, KMTS has received 4 Buy ratings 1 Hold ratings, and 0 Sell ratings. The KMTS average analyst price target in the past 3 months is $27.50.
-
Where Will Kestra Medical Technologies Stock Be In 1 Year?
According to analysts, the consensus estimate is that Kestra Medical Technologies share price will rise to $27.50 per share over the next 12 months.
-
What Do Analysts Say About Kestra Medical Technologies?
Analysts are divided on their view about Kestra Medical Technologies share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Kestra Medical Technologies is a Sell and believe this share price will drop from its current level to $23.00.
-
What Is Kestra Medical Technologies's Price Target?
The price target for Kestra Medical Technologies over the next 1-year time period is forecast to be $27.50 according to 5 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is KMTS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Kestra Medical Technologies is a Buy. 4 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of KMTS?
You can purchase shares of Kestra Medical Technologies via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Kestra Medical Technologies shares.
-
What Is The Kestra Medical Technologies Share Price Today?
Kestra Medical Technologies was last trading at $22.89 per share. This represents the most recent stock quote for Kestra Medical Technologies. Yesterday, Kestra Medical Technologies closed at $22.68 per share.
-
How To Buy Kestra Medical Technologies Stock Online?
In order to purchase Kestra Medical Technologies stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Is a Millionaire-Maker Stock?
From time to time, investors will run across the term…
5 Investors to Follow Other Than Warren Buffett
There is no doubt that Warren Buffett is one of…
Stock Ideas
Buy
68
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 10
Regencell Bioscience Holdings [RGC] is up 79.25% over the past day.
Buy
97
NGVC alert for May 10
Natural Grocers by Vitamin Cottage [NGVC] is up 30.26% over the past day.
Sell
38
ONTO alert for May 10
Onto Innovation [ONTO] is down 30.17% over the past day.
